Product Information

NORVIR 100 MG TABLET is a brand product labeled by AbbVie Inc., priced at $8.3367 per EA under NDC 00074234030. Its NADAC has been published 115 times since Apr 17, 2024.

The High Outlier badge above means this manufacturer's average price in the Ritonavir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

NORVIR 100 MG TABLET

Ritonavir
$8.3367per EA
High Outlier

Strength

100 mg/1

Manufacturer

AbbVie Inc.

NDC

00074234030

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

RITONAVIR

Approval Type

New Drug (NDA)

FDA Application

NDA022417

On Market Since

8/16/2022

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
P-Glycoprotein Inhibitors
Protease Inhibitor
UDP Glucuronosyltransferases Inducers

Price Statistics

The NADAC for NORVIR 100 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$8.3367 per EA
All-time high$8.3505 (Jul 16, 2025)
All-time low$8.3001 (Aug 20, 2025)
52-week high$8.3505
52-week low$8.3001
Median price$8.3416
Average price$8.3394
Largest weekly change+0.5% (Sep 17, 2025)
Weeks tracked115
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

-0.1%

6M

-0.1%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

-0.0%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NORVIR 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NORVIR 100 MG TABLET, manufactured by AbbVie Inc., is $8.3367 per EA (NDC 00074234030), effective Jun 24, 2026.

How has the price of NORVIR 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for NORVIR 100 MG TABLET has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for NORVIR 100 MG TABLET?

Since Apr 17, 2024, the NADAC for NORVIR 100 MG TABLET has ranged from a low of $8.3001 (Aug 20, 2025) to a high of $8.3505 (Jul 16, 2025), with a median of $8.3416 per EA.

Are there cheaper alternatives to NORVIR 100 MG TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RITONAVIR 100 MG TABLET, is $0.6618 per EA — about 92% below NORVIR 100 MG TABLET.

Who manufactures NORVIR 100 MG TABLET?

NORVIR 100 MG TABLET (NDC 00074234030) is labeled by AbbVie Inc., and CMS classifies it as a brand product.